Table 1.
Patient characteristics
| Brazil N=131 (%)* |
Chile N=71 (%)* |
India N=44 (%)* |
Jordan N=182 (%)* |
Korea N=68 (%)* |
USA N=300(%)* |
Total N=796 (%)* |
|
|---|---|---|---|---|---|---|---|
| Age, average (range) | 58 (26-81) | 60 (28-85) | 51 (24-73) | 55 (19-84) | 59 (37-81) | 58 (21-85) | 57 (19-85) |
| Female | 61 (47) | 44 (62) | 26 (59) | 86 (47) | 19 (28) | 144 (48) | 380 (48) |
| Race | |||||||
| Caucasian | 0 | 0 | 0 | 0 | 0 | 229(76) | 229 (29) |
| Black | 0 | 0 | 0 | 0 | 0 | 37 (12) | 37 (5) |
| Hispanic | 131 (100) | 71 (100) | 0 | 0 | 0 | 22 (7) | 224 (28) |
| Asian | 0 | 0 | 44 (100) | 0 | 68 (100) | 11 (4) | 123 (15) |
| Other | 0 | 0 | 0 | 182 (100) | 0 | 1 (0) | 183 (24) |
| Marital status | |||||||
| Single | 16 (12) | 16 (23) | 2 (5) | 19 (10) | 5 (7) | 45 (15) | 103 (13) |
| Married | 85 (65) | 40 (56) | 38 (86) | 139 (76) | 54 (79) | 200 (67) | 556 (70) |
| Divorced | 30 (23) | 15 (21) | 4 (9) | 24 (13) | 9 (13) | 53 (18) | 135 (17) |
| Education | |||||||
| Illiterate | 0 | 0 | 6 (14) | 0 | 0 | 0 | 6 (1) |
| High school or less | 114 (87) | 21 (30) | 32 (73) | 111 (61) | 52 (76) | 77 (26) | 407 (51) |
| Some college up to Bachelor's | 16 (12) | 47 (66) | 5 (11) | 58 (32) | 15 (22) | 173 (58) | 314 (39) |
| Advanced degree | 1 (1) | 3 (4) | 1 (2) | 13 (7) | 1 (2) | 50 (17) | 69 (9) |
| Cancer | |||||||
| Breast | 26 (20) | 11 (15) | 6 (14) | 40 (22) | 3 (4) | 48 (16) | 134 (17) |
| Gastrointestinal | 25 (19) | 26 (37) | 7 (16) | 31 (17) | 33 (49) | 68 (23) | 190 (24) |
| Genitourinary | 30 (23) | 6 (8) | 2 (5) | 14 (8) | 2 (3) | 25 (8) | 79 (10) |
| Gynecological | 16 (12) | 6 (8) | 15 (34) | 7 (4) | 1 (1) | 20 (7) | 65 (8) |
| Head and neck | 5 (4) | 0 | 7 (16) | 18 (10) | 7 (10) | 40 (13) | 77 (10) |
| Hematological | 4 (3) | 8 (11) | 1 (2) | 10 (5) | 6 (9) | 8 (3) | 37 (5) |
| Other | 10 (8) | 6 (8) | 3 (7) | 25 (14) | 3 (4) | 40 (13) | 86 (11) |
| Respiratory | 15 (11) | 8 (11) | 3 (7) | 37 (20) | 13 (19) | 51 (17) | 128 (16) |
| Stage | |||||||
| Advanced | 0 | 0 | 0 | 8 (4) | 4 (6) | 8 (3) | 20 (3) |
| Locally advanced | 23 (18) | 8 (11) | 6 (14) | 9 (5) | 4 (6) | 34 (11) | 84 (11) |
| Metastatic | 108 (82) | 63 (89) | 38 (86) | 165 (91) | 60 (88) | 258 (86) | 692 (87) |
| CAGE positive | 38 (29) | 6 (8) | 6 (14) | 7 (4) | 10 (15) | 43 (14) | 110 (14) |
| MDAS, average (SD) | 2 (1) | 2 (2) | 2 (1) | 3 (2) | 2 (2) | 1 (1) | 2.0 (1.7) |
| KPS, average (SD) | 71 (13) | 78 (13) | 77 (6) | 68 (14) | 77 (11) | NA | 72 (13) |
| Duration between visits, median (Q1, Q3) | 23 (21, 26) | 25 (21, 32) | 17.5 (14, 22) | 21 (15, 28) | 21 (14.5, 25) | 22 (18, 28) | 21 (18, 28) |
*
unless otherwise specified